The effects of dexmedetomidine on residual nephron function after laparoscopic partial nephrectomy through PI3K/AKT signaling pathway: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022025

Enrollment

Unknown

Registered

2019-03-21

Start date

2019-03-19

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Tumor

Interventions

Group D:dexmedetomidine

N group:Saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 80 Patients with kidney tumor, aged 20 to 70 years, ASA I-II, no heart, lung or liver desease undergoing laparoscopic partial nephrectomy will be enrolled into this study at our hospital. A consent form was signed by all patients.

Exclusion criteria

Exclusion criteria: Any conversion to laparotomy, any reason such as bleeding need second operation.

Design outcomes

Primary

Measure	Time frame
pAkt;bcl-2;TLR4;	—

Countries

China

Contacts

Public ContactWang Xiuqin

Shandong Cancer Hospital and Institute

jasmine75@163.com+86 13665416586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026